TARA AMINI: Open Payments
NPI 1508079906 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,904 in 129 payments from 30 companies in 2025. Trend: 2023 $1,005 · 2024 $3,546 · 2025 $5,904
Food & beverage: $5,887Education: $17
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $1,033 |
| Gilead Sciences, Inc. | 9 | $703 |
| Novo Nordisk Inc | 8 | $561 |
| ViiV Healthcare Company | 20 | $504 |
| Amgen Inc. | 10 | $420 |
| Regeneron Healthcare Solutions, Inc. | 5 | $307 |
| Madrigal Pharmaceuticals | 2 | $267 |
| Exact Sciences Corporation | 4 | $188 |
| Indivior Inc. | 9 | $183 |
| Braeburn Inc. | 4 | $170 |
Products named: MAVYRET, Wegovy, APRETUDE, DUPIXENT, REZDIFFRA, REPATHA, OTEZLA, SUBLOCADE.
Industry payments across CA — which companies pay providers there.
